Flow Traders U.S.’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Flow Traders U.S.’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,788	Closed	-$1.98M	–	976
2021 Q3	$1.98M	Buy	1,788 +828	+86%	+$1.02M	0.08%	275
2021 Q2	$1.41M	Buy	960 +383	+66%	+$531K	0.07%	314
2021 Q1	$911K	Buy	577 +449	+351%	+$1.05M	0.05%	347
2020 Q4	$258K	Buy	+128	New	+$204K	0.02%	522
2017 Q1	–	Hold	0	–	–	–	429
2016 Q4	–	Hold	0	–	–	–	549
2016 Q3	–	Sell	-117	Closed	-$66K	–	448
2016 Q2	$66K	Buy	+117	New	+$73.3K	0.01%	229

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

BIM

Bullseye Investment Management Cincinnati, Ohio $164M AUM 8.01% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

HJMC

Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return

Flow Traders U.S.'s LABU Position: Q4 2021 in Review

Flow Traders U.S. sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2021, closing a stake of 1,788 shares — an estimated $1.98M sold.

Flow Traders U.S. first reported a position in LABU in Q2 2016 and held it in 5 quarters. The position peaked at $1.98M in Q3 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q4 2021.

Flow Traders U.S. reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2021 after selling out during the quarter.
Flow Traders U.S. sold 1,788 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2021, an estimated $1.98M.
Flow Traders U.S. first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2016 and held it in 5 quarters.
Flow Traders U.S.'s Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.98M in Q3 2021.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2021.

Based on Flow Traders U.S.'s 13F filing for Q4 2021, filed 14 Feb 2022.